HSF2通过在扩散和入侵之间作为特定阶段的切换驱动乳腺癌的进展
Jenny C Pessa1,2, Oona Paavolainen2,3,4, Hendrik S E Hästbacka1,2
1Faculty of Science and Engineering, Cell Biology, Åbo Akademi University, Turku, Finland.
Science advances
|September 3, 2025
概括
热冲击因子2 (HSF2) 在早期促进乳腺癌细胞的增殖. 转化生长因子-β (TGF-β) 信号减少HSF2,使癌细胞侵入.
科学领域:
- 癌症学
- 分子生物学
- 细胞生物学
背景情况:
- 乳腺癌的进展涉及复杂的细胞表型转变.
- 热冲击因子2 (HSF2) 是一种压力保护转录因子,其对乳腺癌的作用尚不清楚.
- 已知HSF2与各种癌症有关.
研究的目的:
- 研究乳腺癌进展过程中HSF2表达和活性的动态变化.
- 阐明在乳腺癌中调节HSF2功能的分子机制.
- 确定HSF2在乳腺癌发展中的特定阶段作用.
主要方法:
- 分析人类乳腺瘤样本和老鼠异种移植.
- 免疫组织化学评估HSF2表达,局部化和Ki67的联合表达.
- 基于细胞的模型研究转化生长因子β (TGF-β) 对HSF2信号的作用.
- 操纵HSF2水平 (子宫外表达) 以观察其对细胞表型的影响.
主要成果:
- 在本位管道癌 (DCIS) 中增加HSF2表达和核定位,与增殖标志物Ki67相关.
- 在老鼠异种移植中,在从DCIS过渡到侵袭性癌症期间,HSF2的局部化从核转移到细胞质.
- 转化生长因子-β (TGF-β) 信号降低HSF2,促进侵入性细胞表型的获得.
- 恢复HSF2水平抵消了TGF-β信号诱导的侵入性表型.
结论:
- 在乳腺癌中,HSF2作为特定阶段的调节剂,促进早期的扩散 (DCIS),并可能抑制侵袭.
- 转化生长因子-β (TGF-β) 信号传递是调节HSF2活动和局部化的关键机制,推动从扩散转向入侵.
- 针对HSF2或TGF-β信号通路可能为乳腺癌治疗提供新的治疗策略.
相关概念视频
02:07Tumor Progression
6.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K
02:40Cancer Stem Cells and Tumor Maintenance
5.0K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.0K
02:38Mitogens and the Cell Cycle
6.6K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.6K
03:03mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K